載入...
Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
BACKGROUND: Olmesartan medoxomil (OLM), an anti-hypertensive agent administered orally has absolute bioavailability of only 26% due to the poor aqueous solubility (<7.75 μg/ml). The present investigation aimed at enhancing the oral bioavailability of OLM by improving its solubility and dissolutio...
Na minha lista:
Main Authors: | , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Medknow Publications Pvt Ltd
2011
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3178951/ https://ncbi.nlm.nih.gov/pubmed/21966165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0975-7406.84459 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|